Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · IEX Real-Time Price · USD
2.160
-0.100 (-4.42%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Taysha Gene Therapies Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for TSHA stock have an average target of 6.60, with a low estimate of 5.00 and a high estimate of 8.00. The average target predicts an increase of 205.56% from the current stock price of 2.16.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TSHA stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 3 | 3 | 4 | 4 | 5 | 5 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +224.07% | Jul 1, 2024 |
| BMO Capital | BMO Capital | Buy Initiates $5 | Buy | Initiates | $5 | +131.48% | Jun 27, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +131.48% | Jun 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +224.07% | Jun 20, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +224.07% | Jun 19, 2024 |
Financial Forecast
Revenue This Year
11.82M
from 15.45M
Decreased by -23.47%
Revenue Next Year
6.04M
from 11.82M
Decreased by -48.92%
EPS This Year
-0.42
from -0.96
EPS Next Year
-0.48
from -0.42
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.0M | 15.8M | 14.8M | 85.1M | 257.9M |
| Avg | 11.8M | 6.0M | 5.6M | 44.4M | 156.2M |
| Low | 3.3M | n/a | n/a | 14.0M | 54.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 23.0% | 33.2% | 145.6% | 1,407.3% | 481.4% |
| Avg | -23.5% | -48.9% | -6.6% | 686.2% | 252.1% |
| Low | -78.4% | - | - | 147.8% | 23.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.36 | -0.36 | -0.39 | -0.46 | -0.16 |
| Avg | -0.42 | -0.48 | -0.55 | -0.51 | -0.31 |
| Low | -0.52 | -0.64 | -0.67 | -0.55 | -0.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.